scholarly journals Anti-GQ1b ganglioside positive Miller Fisher syndrome – evidence of paranodal pathology on nerve biopsy

2014 ◽  
Vol 1 (2) ◽  
pp. 191-195 ◽  
Author(s):  
James A.L. Miller ◽  
Achillefs Spyropoulos ◽  
Evelyn Jaros ◽  
Francesc Galban-Horcajo ◽  
Roger G. Whittaker ◽  
...  
Keyword(s):  
Nerve Biopsy ◽  
Miller Fisher Syndrome ◽  
Fisher Syndrome ◽  
Gq1b Ganglioside

scholarly journals Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

1993 ◽  
Vol 56 (2) ◽  
pp. 204-206 ◽  
Author(s):  
H J Willison ◽  
J Veitch ◽  
G Paterson ◽  
P G Kennedy
Keyword(s):  
Miller Fisher Syndrome ◽  
Serum Antibodies ◽  
Fisher Syndrome ◽  
Gq1b Ganglioside

scholarly journals Brainstem encephalitis and the Miller Fisher syndrome.

1993 ◽  
Vol 56 (2) ◽  
pp. 201-203 ◽  
Author(s):  
R K Petty ◽  
R Duncan ◽  
G A Jamal ◽  
D Hadley ◽  
P G Kennedy
Keyword(s):  
Miller Fisher Syndrome ◽  
Brainstem Encephalitis ◽  
Fisher Syndrome

54. Unusual course of Miller–Fisher syndrome

2010 ◽  
Vol 121 (4) ◽  
pp. e17
Author(s):  
S. Kostic ◽  
Z. Stevic ◽  
R. Sujic ◽  
V. Cvijanovic ◽  
J. Malovic ◽  
...  
Keyword(s):  
Miller Fisher Syndrome ◽  
Fisher Syndrome

The effectiveness of immunomodulating treatment on Miller Fisher syndrome: a retrospective analysis of 65 Chinese patients

2013 ◽  
Vol 18 (2) ◽  
pp. 195-196 ◽  
Author(s):  
Harrison X. Bai ◽  
Zhi-Li Wang ◽  
Li-Min Tan ◽  
Bo Xiao ◽  
Jonathan M. Goldstein ◽  
...  
Keyword(s):  
Retrospective Analysis ◽  
Miller Fisher Syndrome ◽  
Chinese Patients ◽  
Fisher Syndrome

scholarly journals Recurrent Miller Fisher syndrome: Case report

2021 ◽  
Author(s):  
A. Peral Quirós ◽  
F. Acebrón ◽  
M. del Carmen Blanco Valero ◽  
F. Labella Álvarez
Keyword(s):  
Case Report ◽  
Miller Fisher Syndrome ◽  
Fisher Syndrome

Posterior reversible encephalopathy syndrome following Miller-Fisher syndrome

2021 ◽  
Vol 14 (7) ◽  
pp. e242231
Author(s):  
Catarina Bernardes ◽  
Cristiana Silva ◽  
Gustavo Santo ◽  
Inês Correia
Keyword(s):  
Intravenous Immunoglobulin ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Brain Mri ◽  
Clonic Seizure ◽  
Miller Fisher Syndrome ◽  
Fisher Syndrome ◽  
Posterior Reversible Encephalopathy ◽  
Fluid Analysis ◽  
Immunoglobulin Treatment ◽  
Reversible Encephalopathy

A 71-year-old woman presented to the emergency room with dysphonia, diplopia, dysphagia and generalised weakness since that day. Neurological examination revealed eye adduction limitation, ptosis, hypoactive reflexes and gait ataxia. Blood and cerebrospinal fluid analysis and brain CT were normal. Electromyography revealed a sensory axonal polyneuropathy. She was diagnosed with Miller-Fisher syndrome (MFS) and started on intravenous immunoglobulin. Two days after intravenous immunoglobulin treatment was completed, she developed a sustained hypertensive profile and presented a generalised tonic-clonic seizure. Brain MRI was suggestive of posterior reversible encephalopathy syndrome (PRES) and supportive treatment was implemented with progressive improvement. PRES may be a possible complication of MFS not only due to autonomic and inflammatory dysfunctions, but also as a consequence of its treatment. Patients with MFS should be maintained under close surveillance, especially in the first days and preferably in intermediate care units.

Sign in / Sign up

Export Citation Format

Share Document